In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Acadia Healthcare Company Inc (NASDAQ: ACHC) closed at $14.28 down -1.18% from its previous closing price of $14.45. In other words, the price has decreased by -$1.18 from its previous closing price. On the day, 2.03 million shares were traded. ACHC stock price reached its highest trading level at $14.7 during the session, while it also had its lowest trading level at $14.15.
Ratios:
For a deeper understanding of Acadia Healthcare Company Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On December 03, 2025, BofA Securities Downgraded its rating to Underperform which previously was Neutral but kept the price unchanged to $13.
BofA Securities Downgraded its Buy to Neutral on September 10, 2025, while the target price for the stock was maintained at $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1318709248 and an Enterprise Value of 3818931712. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.11, and their Forward P/E ratio for the next fiscal year is 7.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 1.169 whereas that against EBITDA is 6.093.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.87, which has changed by -0.6430336 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $47.08, while it has fallen to a 52-week low of $12.63. The 50-Day Moving Average of the stock is -27.65%, while the 200-Day Moving Average is calculated to be -37.68%.
Shares Statistics:
For the past three months, ACHC has traded an average of 3.10M shares per day and 4041560 over the past ten days. A total of 90.43M shares are outstanding, with a floating share count of 89.34M. Insiders hold about 3.16% of the company’s shares, while institutions hold 124.77% stake in the company. Shares short for ACHC as of 1764288000 were 14473235 with a Short Ratio of 4.68, compared to 1761868800 on 11301282. Therefore, it implies a Short% of Shares Outstanding of 14473235 and a Short% of Float of 18.66.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is $0.34, with high estimates of $0.47 and low estimates of $0.19.
Analysts are recommending an EPS of between $2.38 and $1.94 for the fiscal current year, implying an average EPS of $2.09. EPS for the following year is $1.97, with 12.0 analysts recommending between $2.45 and $1.48.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $802.84M this quarter.It ranges from a high estimate of $827.18M to a low estimate of $795.8M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $774.24MFor the next quarter, 11 analysts are estimating revenue of $817.16M. There is a high estimate of $835.1M for the next quarter, whereas the lowest estimate is $795.4M.
A total of 11 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.32B, while the lowest revenue estimate was $3.29B, resulting in an average revenue estimate of $3.29B. In the same quarter a year ago, actual revenue was $3.15BBased on 11 analysts’ estimates, the company’s revenue will be $3.44B in the next fiscal year. The high estimate is $3.48B and the low estimate is $3.39B.
